Alert icon
We're changing our privacy policy. This stuff matters.  Learn more  Dismiss

Implications of the TREAT study

Loading...

Sign in or sign up now!
Alert icon
Upgrade to the latest Flash Player for improved playback performance. Upgrade now or more info.
212 views
Loading...
Alert icon
Sign in or sign up now!
Alert icon

Uploaded by on Oct 19, 2010

On October 18, 2010, an FDA advisory panel considered data from the TREAT (Trial to Reduce Cardiovascular Events with Aranesp Therapy) and the implications of the results in dosing the drug in patients with anemia associated with chronic renal failure in patients not yet on dialysis.

  • likes, 0 dislikes

All Comments

Adding comments has been disabled for this video.

Alert icon
0 / 00Unsaved Playlist Return to active list
    1. Your queue is empty. Add videos to your queue using this button:
      or sign in to load a different list.
    Loading...Loading...Saving...
    • Clear all videos from this list
    • Learn more